![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.00 | 13.00 | 35.00 | 24.00 | 24.00 | 24.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.59 | 35.84M |
RNS Number:7607I Cambridge Antibody Tech Group PLC 7 April 2000 CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC ("CAT") EXERCISE OF OVER ALLOTMENT OPTION Deutsche Bank AG London announces that it has partially exercised the Over-Allotment Option referred to in the Prospectus relating to the Open Offer and International Offering of Ordinary Shares in CAT, dated 7 March 2000 and that the stabilisation period has now closed. There will be no further exercise of the Over-Allotment Option. Pursuant to the partial exercise of the Over-Allotment Option, CAT will issue a further 145,667 New Ordinary Shares. For further information contact Tom Kennedy on 020 7545 6298. From: Deutsche Bank AG London END MSCKKOKKOBKDKQK
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions